Exceeding 30 ELNs is strongly recommended for pT3‐4N0 patients with gastric cancer: A multicenter study of survival, recurrence, and prediction modelLulu Zhao, Yingtai Chen, Weili Han et al.|Cancer Science|2021Cited by 20
Resection of the Primary Tumor Improves the Survival of Patients With Stage IV Gastric Neuroendocrine CarcinomaZefeng Li, Dongbing Zhao, Hu Ren et al.|Frontiers in Oncology|2022Cited by 14
Development and Validation of a New Lymph Node Ratio-Based Staging System for Ampullary Carcinoma After Curative PancreaticoduodenectomyXiaojie Zhang, Dongbing Zhao, Chongyuan Sun et al.|Frontiers in Oncology|2022Cited by 10
Better Prognosis of Gastric Neuroendocrine Carcinoma Than Gastric Adenocarcinoma among Whites in the United States: A Propensity Score Matching Analysis Based on SEERZefeng Li, Dongbing Zhao, Chunguang Guo et al.|Current Oncology|2022Cited by 6
Analysis of textbook outcomes for ampullary carcinoma patients following pancreaticoduodenectomyXiaojie Zhang, Dongbing Zhao, Fei He et al.|World Journal of Gastrointestinal Surgery|2023Cited by 6